​Dr. Abeer Al-Qatati is conducting research about miRNAs in prostate cancer at the University Medical Center of Hamburg Eppendorf - Germany. The aim of this study was to establish a unique expression profile of circulating cell-free microRNAs (miRNAs) capable of differentiating between prostate cancer (PCa) patients with high-risk and intermediate-risk Gleason scores. MiRNA expression profiles were determined in plasma samples from 79 treatment-na€ıve PCa patients, 1–2 follow-up samples after radical prostatectomy (RP) from 51 out of the 79 PCa patients, and 33 healthy men, using a quantitative real-time PCR-based array containing 48 selected miRNAs.​​

​